The WACC of Quantum Medical Transport Inc (DRWN) is 32.7%.
Range | Selected | |
Cost of equity | 57694.3% - 89807.9% | 73751.1% |
Tax rate | 5.1% - 7.3% | 6.2% |
Cost of debt | 23.9% - 40.5% | 32.2% |
WACC | 24.6% - 40.7% | 32.7% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 4.6% | 5.6% |
Adjusted beta | 12541.39 | 16036.26 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 57694.3% | 89807.9% |
Tax rate | 5.1% | 7.3% |
Debt/Equity ratio | 28763.14 | 28763.14 |
Cost of debt | 23.9% | 40.5% |
After-tax WACC | 24.6% | 40.7% |
Selected WACC | 32.7% | |
Debt/Equity | Unlevered | |||
Peers | Company Name | ratio | Beta | beta |
DRWN | Quantum Medical Transport Inc | 28763.14 | 0 | 0 |
ENZ | Enzo Biochem Inc | 0.01 | 1.9 | 1.88 |
IDXG | Interpace Biosciences Inc | 1.3 | 1.8 | 0.81 |
IOM.V | Assure Holdings Corp | 0.14 | 1.89 | 1.68 |
NPTH.V | NeuPath Health Inc | 0.8 | 1.12 | 0.64 |
PMD | Psychemedics Corp | 0.02 | 1.03 | 1.02 |
PTQ.V | Protech Home Medical Corp | 0.15 | 1.94 | 1.71 |
STRR | Star Equity Holdings Inc | 1.75 | 0.67 | 0.25 |
XGN | Exagen Inc | 0.14 | 0.83 | 0.74 |
Low | High | |
Unlevered beta | 0.75 | 0.98 |
Relevered beta | 18718 | 23934.22 |
Adjusted relevered beta | 12541.39 | 16036.26 |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for DRWN:
cost_of_equity (73,751.10%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (12541.39) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.